Seeing Green in the Housing Market

Here’s some great news for investors, the housing market is finally starting to heat up. With positive coverage starting to trickle out, now is the opportunity to pick up shares of housing-related stocks while they are still undervalued. Bret Jensen gives his top three picks for an industry that is ready to start moving. It […]

Read more

Obama Vetoes Keystone: Here’s What to Do

Obama’s veto of the Keystone means one thing, railcars will still be the go-to option for moving oil. But, with regulation on the horizon for how crude-by-rail works, there are going to be some underrated winners in the space. We’ve uncovered those winners, and it’s hard to see how an investor goes wrong owning all three […]

Read more

Internal Revenue Growth Sets the Lodging REITs Apart from the Crowd

Want to give your income portfolio a boost this year? If so, read this article to uncover three high quality REITs that are growing their dividends by double digits. Tim Plaehn has done all the work to cherry-pick three of the best REITs in the sector that are not overvalued and great investments right now. […]

Read more

Another Drop in Oil – and an Opportunity to Buy High Yield Upstream MLPs

The big drop in the price of crude has devastated the unit prices of the upstream MLPs. These master limited partnerships own and operate oil and gas wells, so their revenue streams are directly affected by changing energy commodity prices. For long term investors it’s a buyer’s market with many MLPs trading at very attractive […]

Read more

2 Biotech Lottery Tickets to Add to Your Portfolio

I have been quite fortunate over the last six months identifying small biotech and biopharma stocks selling for $5 a share or less that have provided massive subsequent appreciation. In late July I identified Avanir Pharmaceuticals (NASDAQ: AVNR) as one of two inaugural picks for the Small Cap Gems portfolio. This small biopharma rose swiftly […]

Read more

5 Stocks for Finding Stable & High Yields in the Energy Sector

Even after oil prices were cut in just six months, recent negative press, a string of dividend cuts. and fear-mongering have investors continuing to sell everything oil-related. In spite of this, there are still some underrated plays on the beaten down oil industry that can provide investors with stability and income in this time of […]

Read more

When Big Pharma Comes a-calling: 3 Likely Takeover Targets for 2015

Bret Jensen has been outstanding in his biotech picks so far in Q4 and Q1. For investors willing to take on a little risk, the rewards can be truly outstanding. The three companies in this article look like prime take-over candidates, and investors could find themselves enjoying double or triple digit premiums on top of […]

Read more

5 Stocks with Dividend Increases Right around the Corner

When a company raises dividends it’s like getting an automatic pay raise for long term income investors, and for shorter term income traders, a nice boost in returns from dividend holdings. In this article, 30 Day Dividends editor, Tim Plaehn digs through the data and brings you five stocks increasing dividends next month. Act now […]

Read more

Hotel REITs Are Hot

As a group the REIT sector has been red hot. Since a moderate correction in September 2014, the major REIT ETFs are up about 20%. For many REITs, the prices have gotten too rich, making attractive investments more difficult to find. However, there is a subcategory in the sector that is loaded with great companies […]

Read more

2 Cheap Tech Stocks on the Move

It has been a mixed bag for large cap tech companies so far in 2015. IBM Corporation (NYSE: IBM) and Microsoft (NASDAQ: MSFT) posted disappointing quarterly results partly as a result of a strong dollar, something that has been crimping earnings across most American multinationals this earnings season. The strong dollar is having far reaching […]

Read more

Do You Own the Wrong Kind of High-Yield Dividend Stock?

In this article, Tim Plaehn reveals a major red flag that investors should learn to recognize within any potential high-yield investment. It’s something that many people could easily overlook, but so important that this one thing makes the stock an instant do not invest. If you invest for income, learning this strategy could help save […]

Read more

2 More Triple Digit Winners in Biotech

The small cap biotech and biopharma complex has been very kind to everyone who has followed Bret Jensen’s picks over the past half year. Always trying to outdo himself however, here are two more recommendations that have the signature Bret Jensen “X” factors that make up a great small cap biotech investment. Avanir Pharmaceuticals (NASDAQ: […]

Read more

Why Tesla Might Be the Market’s Biggest Mistake of the Year

Tesla is one of the most talked about stocks in the market. But, it is also one of the most misunderstood, with a sky-high valuation based only off of fanciful words from its CEO. Read here to find out what makes the valuation so out of whack, and learn of a handful of better investments […]

Read more